Charles N. Ellis, MD, FAAD
SESSIONS
F070 Updates on Melanoma Diagnosis and Therapy
Mar 9, 2024
•
3:30 PM - 5:30 PM
•
Room 7B
HANDOUTS
Login to view handouts
DISCLOSURES
BirchBioMed – Board of Directors(Stock Options), Consultant(Fees); Formation Bio – Independent Contractor(Stock Options); Lipidio Pharmaceuticals – Independent Contractor(Fees), Independent Contractor(Stock); LS-Psoriasis Global Assessment – Founder(Patent royalties or other compensation for Intellectual Property Rights); Medsphere Systems Corporation – Stockholder(No Compensation Received); Senju Pharmaceutical Co. – Consultant(Fees); Thirona – Independent Contractor(Fees), Independent Contractor(Stock Options); VisualDx – Stockholder(No Compensation Received);